Ecolab trades at a steep premium despite flat sales and only modest benefits from its Ovivo deal, raising concerns about near ...

Current markets are fragile due to leverage, passive flows, and tech concentration. Learn why cash, caution, and active risk ...

Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...

Rhode's launch at Sephora last month showed just how strong the brand already is. Rhode sold an estimated $10 million of product in its first two days, capturing about 35% of Sephora's total sales ...